diphenylamine has been researched along with Airflow Obstruction, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baturcam, E; Bonn, B; Cohen, TS; Cunoosamy, DM; De Zan, E; Kurian, N; Öberg, L; Skogberg, G; Smith, PD; Svanberg, P; Vaarala, O; Vollmer, S | 1 |
| Jacobsen, JR; Klein, U; Linsell, MS; McKinnell, RM; Moran, EJ; Nodwell, MB; Pfeiffer, JW; Thomas, GR; Yu, C | 1 |
2 other study(ies) available for diphenylamine and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPD.
Topics: Adult; Aged; Benzamides; Cells, Cultured; Diphenylamine; Female; Humans; Inflammation; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Middle Aged; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Young Adult | 2019 |
Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Asthma; Cell Line; Diphenylamine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Guinea Pigs; Humans; Molecular Structure; Pulmonary Disease, Chronic Obstructive; Quinolones; Rats; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 2014 |